Go Deep
Lyell Immunopharma, Inc.
Lyell Immunopharma, Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 24,064 | -0.6 | 0.79 | 0.20 | 715.21 |
| Oct 2026 | 23,986 | -0.6 | 0.84 | 0.20 | 758.63 |
| Oct 2026 | 23,953 | -0.6 | 0.86 | 0.20 | 777.73 |
| Oct 2026 | 23,965 | -0.6 | 0.85 | 0.20 | 769.09 |
| Oct 2026 | 23,853 | -0.7 | 0.92 | 0.20 | 834.38 |
| Oct 2026 | 23,706 | -0.8 | 1.02 | 0.20 | 919.72 |
| Oct 2026 | 23,754 | -0.7 | 0.99 | 0.20 | 890.02 |
| Oct 2026 | 23,758 | -0.7 | 0.98 | 0.20 | 885.39 |
Lyell Immunopharma, Inc. Quarterly Results
Quarterly data isn't available for this company right now.
Lyell Immunopharma, Inc. Revenue & Profit
Annual financial data isn't available for this company right now.
Lyell Immunopharma, Inc. Balance Sheet
Balance sheet data isn't available for this company right now.
Owes vs Owns
Lyell Immunopharma, Inc. owed $0.25 for every $1 it owned in Jun 2026, up from $0.11 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.25× | 0.27× | 0.22× | 0.13× | 0.11× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Lyell Immunopharma, Inc. Cash Flow
Cash flow data isn't available for this company right now.